Can the spending of corporate social responsibility be offset? Evidence from pharmaceutical industry
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62690094%3A18450%2F22%3A50019082" target="_blank" >RIV/62690094:18450/22:50019082 - isvavai.cz</a>
Result on the web
<a href="https://www.tandfonline.com/doi/full/10.1080/1331677X.2022.2048194" target="_blank" >https://www.tandfonline.com/doi/full/10.1080/1331677X.2022.2048194</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1080/1331677X.2022.2048194" target="_blank" >10.1080/1331677X.2022.2048194</a>
Alternative languages
Result language
angličtina
Original language name
Can the spending of corporate social responsibility be offset? Evidence from pharmaceutical industry
Original language description
This study aims to investigate whether the costs spent on corporate social responsibility (CSR) can be offset, and identify the inflection point when financial returns from CSR exceed the spending. By using Principal Component Analysis, we developed the Carroll's CSR model to measure actual CSR spending. Drawing on data of 315 listed pharmaceutical firms from China, the quadratic effect was used to examine the inflection point, and the panel data regression was employed to examine the impact of CSR spending on current and subsequent financial performance. The results show that CSR spending cannot be offset in the short-term. After two years of CSR implementation, ethical-domain and overall CSR spending positively relate to return on assets (ROA), whereas legal-domain CSR spending positively affects ROA after three years of CSR implementation, all justifying that CSR spending can be offset in the long-term. This research contributes to literature by precisely recognizing the time-based inflection point in financial performance arises, which is less discussed in existing CSR studies. The study findings imply that corporate managers need to view CSR spending as capital investment rather than operating costs, and policy makers should mandate institutional arrangements to facilitate CSR.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
50201 - Economic Theory
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Economic research-Ekonomska istrazivanja
ISSN
1331-677X
e-ISSN
1848-9664
Volume of the periodical
35
Issue of the periodical within the volume
1
Country of publishing house
GB - UNITED KINGDOM
Number of pages
25
Pages from-to
6279-6303
UT code for WoS article
000768050900001
EID of the result in the Scopus database
2-s2.0-85126523465